• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Epidermal growth factor receptor targeting of replication competent adenovirus enhances cytotoxicity in bladder cancer.

作者信息

van der Poel H G, Molenaar B, van Beusechem V W, Haisma H J, Rodriguez R, Curiel D T, Gerritsen W R

机构信息

Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

出版信息

J Urol. 2002 Jul;168(1):266-72. doi: 10.1097/00005392-200207000-00089.

DOI:10.1097/00005392-200207000-00089
PMID:12050554
Abstract

PURPOSE

We evaluated the delivery and oncolytic potential of targeted replication competent adenoviruses in bladder cancer lines.

MATERIALS AND METHODS

Seven established human bladder cancer tumor lines (5637, SW800, TCCsup, J82, Scaber, T24 and 253J) were studied for the expression of integrins alpha(v)beta3, alpha(v)beta5, Coxsackievirus and adenovirus receptor, epidermal growth factor receptor (EGF-R) and epithelial cell adhesion molecule antigens using flow cytometry analysis. Bispecific single chain Fv fragments were used to target replication deficient luciferase reporter adenovirus to EGF-R (425-s11) or to epithelial cell adhesion molecule (C28-s11) antigens. Moreover, a fiber modified adenovirus targeting alpha(v)-integrins was studied. Replication competent serotype-5 adenoviruses attenuated to replicate specifically in retinoblastoma pRb (Ad5-d24) or p53 deficient (Ad5-d55K) cells were tested in vitro for oncolytic properties.

RESULTS

Low to absent Coxsackievirus and adenovirus receptor expression was found in 5 of the 7 tumor lines (SW800, J82, T24, 5637 and Scaber). EGF-R expression was found in all cell lines, whereas elevated epithelial cell adhesion molecule expression was seen in 3 (5637, Scaber and TCCsup), alpha(v)beta3-integrin was found in 1 (Scaber) and alpha(v)beta5-integrin was found in 3 (TCCsup, 253J and T24). EGF-R targeting using 425-s11 improved transgene expression in all cell lines from 2.1 to 12.5 times over nontargeted viruses. Epithelial cell adhesion molecule and integrin targeting was inferior to EGF-R targeting with a maximal increase in transgene expression of 2 times for epithelial cell adhesion molecule in 5637cells and 1.6 times for integrin targeting in T24 cells. Comparison of the wild-type replication competent virus with conditionally replicating adenoviruses (Ad5-d55K and Ad5-d24) showed superior oncolytic activity for the latter 2 in all lines. Furthermore, improved cytotoxicity (29% to 33%) was obtained in 4 of the 7 lines after pre-incubation of Ad5-d24 with 425-s11.

CONCLUSIONS

EGF-R directed bispecific single chain antibodies enhance adenovirus mediated transgene expression and oncolysis in bladder cancer lines.

摘要

相似文献

1
Epidermal growth factor receptor targeting of replication competent adenovirus enhances cytotoxicity in bladder cancer.
J Urol. 2002 Jul;168(1):266-72. doi: 10.1097/00005392-200207000-00089.
2
Fiber-substituted conditionally replicating adenovirus Ad5F35 induces oncolysis of human bladder cancer cells in in vitro analysis.纤维取代条件复制腺病毒 Ad5F35 在体外分析中诱导人膀胱癌细胞的溶瘤作用。
Urology. 2013 Apr;81(4):920.e7-11. doi: 10.1016/j.urology.2012.12.023. Epub 2013 Feb 8.
3
Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function.培养的肺腺癌细胞对5型腺病毒的摄取与Ad5纤维结合相关,由α(v)β1整合素介导,并且可通过β1整合素功能的变化进行调节。
J Gene Med. 2001 Nov-Dec;3(6):550-9. doi: 10.1002/jgm.223.
4
Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors.整合素靶向溶瘤腺病毒 Ad5-D24-RGD 和 Ad5-RGD-D24-GMCSF 治疗晚期化疗耐药实体瘤患者。
Int J Cancer. 2012 Apr 15;130(8):1937-47. doi: 10.1002/ijc.26216. Epub 2011 Aug 8.
5
E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers.具有RGD纤维修饰的E1A、E1B双限制腺病毒对缺乏CAR的胆管癌表现出增强的溶瘤作用。
Clin Cancer Res. 2007 May 15;13(10):3043-50. doi: 10.1158/1078-0432.CCR-06-2103.
6
The growth inhibitory effect of p21 adenovirus on human bladder cancer cells.p21腺病毒对人膀胱癌细胞的生长抑制作用。
J Urol. 2000 Mar;163(3):1033-8.
7
Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer.整合素α(v)与柯萨奇腺病毒受体在临床膀胱癌中的表达
Urology. 2002 Sep;60(3):531-6. doi: 10.1016/s0090-4295(02)01748-x.
8
Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.用表达单纯疱疹病毒胸苷激酶的复制型腺病毒载体治疗恶性胶质瘤。
Cancer Res. 2001 Dec 15;61(24):8743-50.
9
Conditionally replicative adenovirus with tropism expanded towards integrins inhibits osteosarcoma tumor growth in vitro and in vivo.对整合素具有趋向性的条件性复制腺病毒在体外和体内均可抑制骨肉瘤肿瘤生长。
Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):61-7. doi: 10.1158/1078-0432.ccr-0609-03.
10
Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105).通过一种双特异性单链双抗体将腺病毒靶向内皮细胞,该双特异性单链双抗体针对腺病毒纤维钮结构域和人内皮糖蛋白(CD105)。
Mol Ther. 2001 Jun;3(6):882-91. doi: 10.1006/mthe.2001.0342.

引用本文的文献

1
Oncolytic Adenovirus, a New Treatment Strategy for Prostate Cancer.溶瘤腺病毒,一种前列腺癌的新治疗策略。
Biomedicines. 2022 Dec 15;10(12):3262. doi: 10.3390/biomedicines10123262.
2
Oncolytic Viruses for the Treatment of Bladder Cancer: Advances, Challenges, and Prospects.用于治疗膀胱癌的溶瘤病毒:进展、挑战与前景
J Clin Med. 2022 Nov 26;11(23):6997. doi: 10.3390/jcm11236997.
3
Efficacy and Safety of Oncolytic Viruses in Randomized Controlled Trials: A Systematic Review and Meta-Analysis.溶瘤病毒在随机对照试验中的疗效与安全性:一项系统评价和荟萃分析
Cancers (Basel). 2020 May 30;12(6):1416. doi: 10.3390/cancers12061416.
4
Increasing the efficacy of oncolytic adenovirus vectors.提高溶瘤腺病毒载体的疗效。
Viruses. 2010 Sep;2(9):1844-1866. doi: 10.3390/v2091844. Epub 2010 Aug 27.
5
Virotherapy induces massive infiltration of neutrophils in a subset of tumors defined by a strong endogenous interferon response activity.病毒疗法在由强烈内源性干扰素反应活性定义的肿瘤亚群中诱导大量中性粒细胞浸润。
Cancer Gene Ther. 2011 Nov;18(11):785-94. doi: 10.1038/cgt.2011.46. Epub 2011 Aug 26.
6
Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptor.靶向表皮生长因子受体或尿激酶型纤溶酶原激活物受体过表达的肿瘤细胞的重定向腺病毒癌症基因治疗。
Gene Ther. 2010 Aug;17(8):1000-10. doi: 10.1038/gt.2010.45. Epub 2010 Apr 22.
7
Polymer-enhanced adenoviral transduction of CAR-negative bladder cancer cells.聚合物增强CAR阴性膀胱癌细胞的腺病毒转导
Mol Pharm. 2009 Sep-Oct;6(5):1612-9. doi: 10.1021/mp9000958.
8
Evolving gene therapy approaches for osteosarcoma using viral vectors: review.使用病毒载体的骨肉瘤基因治疗方法的进展:综述
Bone. 2007 Apr;40(4):797-812. doi: 10.1016/j.bone.2006.10.017. Epub 2006 Dec 26.
9
Primary targeting of recombinant Fv-immunotoxin hscFv(25)-mTNFalpha against hepatocellular carcinoma.重组Fv免疫毒素hscFv(25)-mTNFα对肝细胞癌的原发性靶向作用
World J Gastroenterol. 2004 Jul 1;10(13):1872-5. doi: 10.3748/wjg.v10.i13.1872.
10
Genetically targeted adenovirus vector directed to CD40-expressing cells.靶向表达CD40细胞的基因工程腺病毒载体。
J Virol. 2003 Nov;77(21):11367-77. doi: 10.1128/jvi.77.21.11367-11377.2003.